From Frontiers Forum:
How can research translate to R&D? Or a whole new business venture? In a panel session at Science Unlimited 2019, Holtzbrinck Publishing Group CEO Stefan von Holtzbrinck, Life Biosciences CEO Mehmood Khan, Logitech CEO Bracken Darrell and EPFL’s Henry Markram discussed innovation, R&D and successful technology transfer.
Stefan von Holtzbrinck, Holtzbrinck Publishing Group
Stefan von Holtzbrinck is CEO of the family-owned Holtzbrinck Publishing Group. He has 20 years’ experience in science communication, including 3 years as MD of Nature Publishing Group. The Holtzbrinck Publishing Group has majority holdings in Springer Nature (of which Stefan is Chairman of the Supervisory Board), Digital Science, DIE ZEIT and Macmillan, and investments in Holtzbrinck Ventures, Frontiers, AMBOSS, GSV AcceleraTE and Rethink Education fund. Stefan is a member of the Executive Committee of the Max Planck Society.
Mehmood Khan, Life Biosciences
Mehmood Khan is CEO and Board Member of Life Biosciences Inc, where he provides strategic direction and operational oversight. He was previously Vice Chairman and Chief Scientific Officer of Global Research and Development at PepsiCo and President of Global R&D at Takeda Pharmaceuticals. Before moving into industry, Mehmood had a distinguished medical career, including as a faculty member in endocrinology at the Mayo Clinic and Mayo Medical School where he served as Director of the Diabetes, Endocrine and Nutritional Trials Unit.
Bracken Darrell, Logitech
Bracken Darrell is President and CEO of Logitech, the largest Swiss consumer electronics company with CHF 3 billion in annual revenues. He is responsible for the company’s strategy for growth and profitability, for the vision for the brand as well as for the company’s operations. Logitech has been a top performer on both the Nasdaq and Swiss stock exchanges. The company value has risen by over 500 percent in the past seven years as the company has moved from PC peripherals to new categories and new brands.
Henry Markram, EPFL
Henry Markram has pioneered simulation neuroscience as a new path to understanding how the brain works. As Professor of Neuroscience at the Swiss Federal Institute of Technology in Lausanne (EPFL), he founded the Brain Mind Institute, the Blue Brain Project and the Human Brain Project, a €1 Billion European initiative to simulate the brain. His research has shifted from experimentally reverse engineering neocortical tissue to developing a software ecosystem and algorithms to convert biological data into detailed digital reconstructions of brain tissue.
Image Credit: Amanda Scott – Alias Studio Sydney
News This Week
Silver and titanium nanomaterials present in wastewater may have toxic effects on crustaceans and fish cells
You may not always think about it when you do your laundry or flush the toilet; but whatever you eat, wear or apply on your skin ends up in wastewater and eventually reaches the [...]
Boston University researchers have developed a new, "intelligent" metamaterial – which costs less than ten dollars to build – that could revolutionize magnetic resonance imaging (MRI), making the entire MRI process faster, safer, and [...]
We can directly see the hidden world of atoms thanks to electron microscopes, first developed in the 1930s. Today, electron microscopes, which use beams of electrons to illuminate and magnify a sample, have become [...]
In her inaugural podcast, Jamilee interviews Frank Boehm of NanoApps Medical Inc and NanoApps Athletics Inc. From Jamilee's podcast: Welcome to the first episode of "In a Click". On todays show I chat with [...]
“We’ll have nanobots that… connect our neocortex to a synthetic neocortex in the cloud. Our thinking will be a…. biological and non-biological hybrid.” Ray Kurzweil, TED 2014 UPDATE - October 30 2019 Since [...]
We humans have evolved a rich repertoire of communication, from gesture to sophisticated languages. All of these forms of communication link otherwise separate individuals in such a way that they can share and express [...]
Ultrasensitive nanoscale optical probes have been created by scientists from UC Santa Cruz, to observe the bioelectric activity of neurons and other excitable cells. This innovative readout technology could allow researchers to analyze how [...]
Advances made during recent clinical trials mean that those suffering from celiac disease may soon be able to reintroduce gluten back into their diet. This breakthrough is down to a progressive new treatment that [...]
A new way of editing the code of life could correct 89% of the errors in DNA that cause disease, say US scientists. The technology, called prime editing, has been described as a "genetic [...]
A research team of Ehime University paved a way to achieve unexplored III-V semiconductor nanostructures. They grew branched GaAs nanowires with a nontoxic Bi element employing characteristic structural modifications correlated with metallic droplets, as [...]
While many people love colorful photos of landscapes, flowers or rainbows, some biomedical researchers treasure vivid images on a much smaller scale – as tiny as one-thousandth the width of a human hair. To [...]
Energy is information. Lengthening the time during which a system is capable of retaining energy before losing it to the local environment is a key goal for the development of quantum information. This interval [...]
Just because a model catalyst effectively drives a reaction in a well-controlled environment doesn’t mean it will work as well under more practical conditions. For years, scientists have strived to predict catalysts’ performance. In [...]
Particles that are mere nanometers in size are at the forefront of scientific research today. They come in many different shapes: rods, spheres, cubes, vesicles, S-shaped worms and even donut-like rings. What makes them [...]